Adamson, C. et al. 2009. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opinion on Investigational Drugs 8(18): 1061-1083. So far, I have only read the abstract, but this one looks like it might provide a good comprehensive overview of the current state of the science.
Heimberger, AB & Sampson, JH. 2009. The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients. Expert Opinion on Biological Therapy 9(8): 1087-1096. Seems like a potentially promising approach though I don't know if my little goblin had the requisite EGFR variant III.
Labels: Cancer Biology